Fred D. Lublin - Publications

Publications

Partial list:

• Lublin, F.D., Whitaker, J.N., Eidelman, B.H., Miller, A.E., Arnason, B.G.W. and Burks, J.S. Management of Patients Receiving Interferon Beta-1b for Multiple Sclerosis: Report of a Consensus Conference. Neurology 46:12-18, 1996. PMID 8559358

• Lublin, F.D. and Reingold, S.C. Defining the Clinical Course of Multiple Sclerosis: Results of an International Survey. Neurology 46:907-911, 1996. PMID 8780061

• Lublin, F.D., Reingold, S.C. and the National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Guidelines for Clinical Trials of New Therapeutic Agents in Multiple Sclerosis: Relations Between Study Investigators, Advisors and Sponsors. Neurology 48:572-574, 1997. PMID 9065528

• Croul, S. Lublin, F.D., Del Valle, L., Oshinsky, R.J., Giordano, A., Khalili, K. & Ritchie, C.K. The Cellular Response of JC Virus T-Antigen-Induced Brain Tumor Implants to a Murine Intra-Ocular Model. Journal of Neuroimmunology 106:181-188, 2000. PMID 10814796

• Kalman, B. and Lublin, F.D. Spectrum and classification of inflammatory demyelinating diseases of the central nervous system. Current Neurology and Neuroscience Reports, Demyelinating Disorders section 1:249-256, 2001. PMID 11898526

• Lublin, F.D., Reingold, S.C. and The National Multiple Sclerosis Society (USA) Task Force on Placebo-Controlled Clinical Trials in MS. Placebo-Controlled Clinical Trials in Multiple Sclerosis: Ethical Considerations. Annals of Neurology 49:677-681, 2001. PMID 11357961

• Tullman, M.J., Lublin, F.D. and Miller, A.E. Immunotherapy of Multiple Sclerosis- Current Practice and Future Directions. Journal of Rehabilitation Research and Development 39:273-286, 2002. PMID 12051470

• Lublin, F.D. The Diagnosis of Multiple Sclerosis. Current Opinion in Neurology 15:253-256, 2002. PMID 12045721

• Lublin, F.D. Modernize Your Approach to Multiple Sclerosis. Practical Neurology 1:44-49, 2002.

• Lublin, F.D., Baier, M. and Cutter, G. Effect of Relapses on Development of Residual Deficit in Multiple Sclerosis. Neurology 61:1528, 2003. PMID 14663037

• Lublin, F.D. History of Modern Multiple Sclerosis Therapy. Journal of Neurology 252 (Supple 3):3-9, 2005. PMID 16170498

• Lublin, F.D. Multiple Sclerosis Trial Designs for the 21st Century: Building on Recent Lessons. Journal of Neurology 252 (Supple 5):46-53, 2005. PMID 16254702

• Lublin, F.D. The Incomplete Nature of Multiple Sclerosis Relapse Reduction. Journal of Neurological Science 256: S14-18, 2007. PMID 17337274

• DeAngelis T and Lublin F .D. Neurotherapeutics in Multiple Sclerosis: Novel Agents and Emerging Treatment Strategies. Mount Sinai Journal of Medicine 75:157-19-67, 2008. PMID 18500719

• Fazekas, F., Lublin, F.D., Li, D., Freedman, M.S., Hartung, H.P., Rieckmann, P., Soelberg Sørensen, P., Maas-Enriquez, M., Sommerauer, B., Hanna, K. For the PRIVIG Study Group, the UBC MS/MRI Research Group. Intravenous Immunoglobulin in Relapsing-Remitting Multiple Sclerosis - A Dose-Finding Trial. Neurology 71:265-271, 2008. PMID 18645164